NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

The priority vouchers are, as usual, much ado about nothing as related to DCVax-L.

First and foremost, if NWBO is ready for an FDA approval in 1-2 months (they aren’t) why didn’t they submit a BLA 6 months ago? They haven’t even submitted an application for a process that currently takes 8-10 months. Why on God’s green earth do you folks think they are now going to be ready in 1-2 months just because the FDA turnaround is faster? Spoiler alert - they aren’t. NWBO hasn’t been waiting on the FDA, it’s the other way around.

Second, the article clearly states:

“Using a common-sense approach, the national priority review program will allow companies to submit the lion’s share of the drug application before a clinical trial is complete so that we can reduce inefficiencies. The ultimate goal is to bring more cures and meaningful treatments to the American public,”

That didn’t happen. So DCVax-L isn’t really a prime candidate at all for this program.

It may help Direct or other pipeline treatments we don’t know about if NWBO survives. But this impacts -L exactly zero.

Please folks, do your own due diligence. Don’t trust the garbage AI bots and morons posting nonsense. It’s getting out of hand.

(I said “you” a lot, this isn’t directed at you Mani, just replied to your post)